Brasilia zeroes tariffs on six strategic imports and multiplies a medical device quota, using a Mercosur supply mechanism to cool input costs while the world’s tariff walls rise
International Trade Desk, Peacock Tariff Consulting | July 21, 2026
BRASILIA, July 21, 2026: Brazil has moved in the opposite direction of much of the trading world this week, slashing import tariffs to zero on a basket of six industrial and agricultural inputs and dramatically expanding duty-free access for medical device components. The measure, adopted by the Executive Management Committee of the Brazilian Foreign Trade Chamber, known as GECEX, arrives at a moment when most headlines in global trade are dominated by new barriers rather than new openings.
Resolution No. 939, signed on July 17 and announced by GECEX on July 20, was published in Brazil’s Official Gazette, the Diario Oficial da Uniao, on July 21. According to the published text, the resolution amends Annex IV of GECEX Resolution No. 272 of November 2021, the legal home of Brazil’s list of temporary tariff reductions granted for supply reasons under Mercosur rules. The first tranche of the new zero-duty quotas enters into force on July 23 and runs for a full year, through July 22, 2027.
The timing is striking. Brazil’s exporters are bracing for a new 25 percent United States tariff on many Brazilian goods that takes effect this week, and the government in Brasilia has spent recent days weighing responses to that external shock. Yet on the import side of the ledger, the country’s trade policymakers have chosen liberalization, at least for a carefully selected set of products where domestic supply cannot keep pace with demand.
What the resolution does
The heart of Resolution No. 939 is a set of temporary tariff-rate quotas that reduce the in-quota import duty to zero for six products, according to the resolution as recorded by the Global Trade Alert, the Swiss-based trade policy monitoring initiative that catalogued the measure within a day of its gazette publication.
The first item is hops extract, classified under Mercosur nomenclature code 1302.13.00, which receives a 1,200 tonne annual quota at zero duty. Outside the quota, the regular common external tariff of 7.2 percent continues to apply. Brazil’s booming craft brewing sector depends almost entirely on imported hops and hop products, since domestic cultivation remains marginal, and brewers have long lobbied for cheaper access to the ingredient.
The second is acephate, an organophosphate insecticide classified under code 2930.90.61, which receives a 30,000 tonne quota at zero duty against an out-of-quota rate of 10.8 percent. Acephate is widely used in Brazilian soybean and cotton production, and crop input costs have been a persistent complaint of the farm lobby, one of the most powerful constituencies in Brazilian trade politics.
Third on the list are medicines containing the diabetes treatment combination of empagliflozin and linagliptin, classified under code 3004.90.59, with a quota of 70 tonnes at zero duty and an out-of-quota tariff of 7.2 percent. The inclusion reflects rising demand for modern antidiabetic therapies in Brazil’s public and private health systems.
The fourth product is calcium caseinate powder, a milk protein used in food manufacturing and clinical nutrition, classified under code 3501.90.19, with a 700 tonne quota and a 12.6 percent out-of-quota rate. Fifth is polyamide-6 in granule form, a nylon feedstock classified under code 3908.10.25, which receives a 900 tonne quota against the same 12.6 percent external rate. Polyamide granules feed Brazil’s plastics and automotive parts industries, where processors have reported difficulty sourcing sufficient domestic material at competitive prices.
The sixth and arguably most commercially significant item is universal electric motors, classified under code 8501.20.00, which receive a quota of 11.5 million units at zero duty. The out-of-quota tariff for these motors is 18 percent, among the higher rates in Brazil’s industrial tariff schedule, so the quota represents a substantial saving for the household appliance and power tool manufacturers that consume these motors in volume.
A sixty-fold expansion for injector pen parts
Alongside the six new zero-duty quotas, Resolution No. 939 delivers a dramatic expansion of an existing concession. The in-quota volume for components used to manufacture disposable medication injector pens, classified under code 9018.39.99, jumps from 9,919,980 units to 58.2 million units, according to the Global Trade Alert record of the measure. That expanded quota takes effect on August 20, 2026 and runs until August 19, 2027. The out-of-quota tariff remains 16 percent.
The injector pen expansion is a window into one of the fastest-growing corners of the global pharmaceutical market. Injector pens are the delivery mechanism for insulin and, increasingly, for the blockbuster class of GLP-1 medications used in diabetes and obesity treatment. Brazil has attracted investment in local filling and assembly of such therapies, and component demand has surged accordingly. A quota nearly six times larger than its predecessor suggests regulators anticipate explosive growth in domestic assembly volumes.
The resolution also extends existing tariff quotas for two other products, palm kernel oil fractions under code 1513.29.19 and titanium oxides under code 2823.00.10, keeping in place concessions that were due to lapse. Taken together, the package touches nine product lines across food, chemicals, plastics, pharmaceuticals and electrical machinery.
The Mercosur machinery behind the measure
Brazil cannot simply cut its import tariffs unilaterally. As a founding member of Mercosur, the customs union with Argentina, Paraguay and Uruguay, Brazil applies the bloc’s common external tariff, and deviations require a legal basis agreed at the regional level. Resolution No. 939 rests on Mercosur Common Market Group Resolution No. 49 of 2019, a mechanism that allows member states to reduce tariffs temporarily when domestic supply of a product is insufficient, a situation the rules describe as supply shortage or desabastecimento.
The Mercosur Trade Commission authorized these specific Brazilian quotas through a series of directives issued in 2026, numbered 129 through 141, according to the sources catalogued with the measure. The mechanism caps how many products each member may cover and requires evidence that regional producers cannot meet demand, a discipline meant to prevent the supply-shortage window from swallowing the common external tariff entirely.
Trade lawyers note that the supply-reason list has become one of the most actively managed instruments in Brazilian trade policy. Because concessions are temporary, typically twelve months, the list functions as a rolling pressure valve. Industries facing input shortages petition GECEX, technical staff evaluate domestic production capacity, and the committee calibrates quota volumes to fill the gap without undercutting local producers beyond it.
The Global Trade Alert, which evaluates trade measures by their effect on foreign commercial interests, classified the new quotas as liberalizing, its green designation, since they improve market access for foreign suppliers. Its records indicate the beneficiaries span dozens of trading partners, with suppliers in China, the European Union, Japan, South Korea, India, Mexico and Vietnam among those positioned to gain, depending on the product.
Inside Brazil’s tariff bureaucracy
Understanding who made this decision helps explain what it signals. Trade policy in Brazil runs through the Chamber of Foreign Commerce, known as CAMEX, an interministerial body chaired by the Ministry of Development, Industry, Trade and Services. Its executive arm, GECEX, is the committee that actually votes tariff changes, meeting on a regular cycle and issuing numbered resolutions that alter the tariff schedule line by line. Resolution No. 939 is one of hundreds the committee has issued since the current framework was consolidated in Resolution No. 272 of November 2021, the master document whose annexes hold both the standard tariff schedule and the various exception lists.
The supply-reason list sits alongside a separate and older instrument, the list of exceptions to the common external tariff known as LETEC, which allows each Mercosur member to deviate from the common tariff on a capped number of product lines for policy reasons of its own choosing. The supply mechanism is narrower and more disciplined: it requires a demonstrated shortage, imposes volume caps through quotas rather than open-ended rate changes, and expires automatically. That discipline is precisely why the Mercosur partners tolerate its frequent use, and why trading partners rarely object; the measure expands access rather than restricting it.
Petitioning companies must document domestic production capacity, demand projections and the gap between them. Competing domestic producers get the opportunity to contest the numbers, and the Mercosur Trade Commission provides a second layer of review before directives authorizing the quotas are issued. The process is slower than businesses would like, often taking months from petition to publication, which is why importers who anticipate structural shortages file early and treat the annual renewal cycle as a permanent feature of their government affairs calendar.
Liberalizing at home while walls rise abroad
The broader context makes this routine-sounding administrative act unusually interesting. Brazil finds itself squeezed between two of the defining trade confrontations of 2026. Washington’s new 25 percent tariff on a wide range of Brazilian exports, announced in mid-July following a Section 301 finding on what the United States called unfair trade practices, takes effect on July 22, one day before Brazil’s own liberalizing quotas begin. Brasilia has said it will challenge the American measure, and President Luiz Inacio Lula da Silva has publicly rejected its premise, with officials signaling recourse to the World Trade Organization’s dispute settlement mechanism, according to reporting by CNBC and other outlets.
At the same time, Brazil’s largest single trade relationship of the future may be taking shape across the Atlantic. The interim trade agreement between the European Union and Mercosur has applied provisionally since May 1, 2026, according to an analysis by the law firm White and Case, beginning the long phase-out of tariffs between the two blocs after a quarter century of negotiation. Ratification steps concluded on the South American side earlier this year, with Brazil completing its process in February and Paraguay, the last member, in March.
Against that backdrop, the supply-reason quotas illustrate a quieter truth about Brazilian trade policy: whatever the rhetoric of the moment, the country’s industrial and agricultural base depends heavily on imported inputs, and the government has concluded that keeping those inputs cheap is worth more than the protection the common external tariff would otherwise provide. Brazil’s average applied tariff remains among the highest of any major economy, which makes these targeted openings all the more valuable to the companies that secure them.
Who gains, product by product
For foreign exporters, the quotas open a window that rewards speed. Brazilian tariff-rate quotas under the supply mechanism are typically administered on a first-come, first-served basis through import licensing, meaning early shippers capture the duty-free volumes. Suppliers of hops extract in Germany, the United States and the Czech Republic, acephate producers in China and India, European and Asian pharmaceutical manufacturers, dairy protein processors in New Zealand and the EU, polyamide producers across East Asia, and electric motor plants in China and Southeast Asia all have a concrete commercial reason to review their Brazilian order books this week.
For Brazilian importers, the savings are straightforward to calculate. An appliance maker importing motors worth 100 million dollars a year at the 18 percent rate stands to save up to 18 million dollars if its volumes fit within the quota. A brewer paying 7.2 percent on hops extract sees that cost line go to zero. In an economy where high interest rates have squeezed manufacturing margins, duty relief of this scale can be the difference between expanding a production line and idling it.
The medical products tell a more strategic story. Zeroing duties on a modern diabetes therapy while multiplying the component quota for injector pens signals that Brazil wants to position itself as a regional assembly and distribution hub for high-demand pharmaceuticals. Health economists have long argued that Brazil’s public health system, which provides diabetes medication at no cost to patients, is acutely sensitive to import costs for these categories.
The list of affected trading partners catalogued with the measure runs to more than thirty jurisdictions, from Austria and Belgium through Israel, Indonesia and South Korea to Vietnam, reflecting how globally diversified the supply base is for these products. That breadth matters diplomatically as well as commercially. Because the concession applies on a most-favored-nation basis to all origins rather than favoring any single partner, it generates goodwill across the membership of the World Trade Organization at a moment when Brazil is preparing to invoke that organization’s dispute machinery in its confrontation with Washington. A country heading into a WTO complaint benefits from being seen to liberalize.
The reaction from industry
Reactions from Brazilian industry associations tend to split along predictable lines whenever GECEX trims the tariff wall. Import-dependent manufacturers welcome the relief, while producers who compete with the imported goods complain of erosion of the common external tariff. The National Confederation of Industry has historically supported the supply-shortage mechanism as a safety valve, provided quota volumes are calibrated to genuine gaps in domestic capacity, a condition the Mercosur directives are designed to police.
Farm groups, for their part, have pressed hard for cheaper crop protection inputs as global agrochemical prices remain elevated. The 30,000 tonne acephate quota answers part of that demand. Brazilian growers plant the world’s largest soybean crop, and input cost inflation has been a recurring theme in the farm lobby’s engagement with Brasilia throughout the 2025-26 season.
There is also a competitiveness argument that runs through the whole package. With the United States raising barriers to Brazilian goods, Brazilian exporters will need to find margin wherever they can to stay competitive in alternative markets. Cheaper inputs, from nylon granules to electric motors, feed directly into the cost base of Brazilian finished goods sold across Latin America, Europe and Asia.
What it means for global supply chains
For international supply chain managers, Brazil’s move carries several practical lessons. First, the measure is time-limited. The zero-duty window for the six new products closes on July 22, 2027, and the expanded injector pen quota on August 19, 2027, unless renewed. Procurement teams should treat the window as an opportunity to build inventory or negotiate annual contracts that front-load deliveries into the quota period.
Second, quota administration matters as much as the headline rate. Companies that have not previously shipped under Brazilian tariff-rate quotas will need to master the licensing workflow, coordinate with customs brokers on quota balance monitoring, and time entries to avoid arriving after volumes are exhausted. Experience with earlier supply-reason quotas suggests popular items can fill quickly, particularly where the duty differential is large, as with the 18 percent motor tariff.
Third, the measure is a reminder that Mercosur’s common external tariff is more porous than its reputation suggests. Between the supply-shortage mechanism, the separate list of capital goods exceptions, and the gradual liberalization now beginning under the EU-Mercosur interim agreement, the effective tariff a given product faces in Brazil can differ sharply from the published schedule. Companies that treat the schedule as fixed leave money on the table; those that track GECEX’s monthly resolutions can find recurring openings.
Finally, the package underscores how trade policy is increasingly made in fragments. A year of zero duty on hops extract will not make headlines alongside the great tariff confrontations of 2026, but for the companies affected, the percentage swings are comparable. The sum of many small, technical measures like Resolution No. 939 shapes real trade flows as surely as the marquee disputes do.
The renewal question
A recurring theme in conversations with trade practitioners in Sao Paulo is the uncertainty that surrounds expiry. Some supply-reason quotas are renewed year after year, becoming de facto permanent openings; others lapse when domestic capacity comes online or political winds shift. The palm kernel oil and titanium oxide extensions in this very resolution show renewal in action, while the injector pen expansion shows how volumes get recalibrated upward when demand outruns the original estimate.
That uncertainty has commercial consequences. A manufacturer deciding whether to design a Brazilian product line around an imported motor at zero duty must weigh the risk that the quota disappears in twelve months and the 18 percent tariff snaps back. The rational response, visible in how sophisticated importers behave, is to treat quota-year savings as a windfall to be locked in through inventory and contract timing, not as a permanent input price to be built into long-run product economics. Suppliers, conversely, use the quota year to establish qualification, certification and customer relationships that can survive a return of the duty.
There is also a political economy pattern worth noting. Measures that cut costs for farmers and health systems tend to be renewed, because their constituencies are broad and vocal. Measures that primarily benefit a handful of industrial importers face tougher renewal odds when domestic producers mobilize. Companies betting on renewal should map which category their product falls into and engage the process early rather than assume the past predicts the future.
Outlook
GECEX meets regularly and the supply-reason list will keep evolving. Brazilian officials have signaled that further quota requests are in the pipeline for the committee’s coming sessions, spanning chemicals, food ingredients and electronic components. Meanwhile, the twin external dramas, the American tariff taking effect this week and the EU-Mercosur agreement’s staged implementation, will keep pulling Brazilian trade policy in opposite directions: retaliation and defense on one side, integration and liberalization on the other.
There is a longer-run question worth watching: whether Mercosur’s members eventually consolidate the proliferating exception lists into a genuine revision of the common external tariff. Economists have argued for years that the bloc’s tariff structure, designed in the 1990s, no longer matches its members’ industrial realities, and the accumulating patchwork of quotas and carve-outs is the symptom. The EU agreement’s implementation may force that conversation, since staged liberalization toward Europe will sit awkwardly beside high tariffs toward everyone else.
For now, the message from Brasilia to global suppliers is simple and, in the current climate, refreshingly rare: for these nine product lines, at these volumes, for the next twelve months, the door is open and the duty is zero.